Quick Order Cart

Cat. No. ARG32704

ITGA3 Knockout SK-HEP-1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Liver

  • Disease:

    Adenocarcinoma

The ITGA3 Knockout SK-HEP-1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population derived from the human hepatic sinusoidal endothelial cell line SK-HEP-1, featuring disruption of the integrin alpha-3 gene (ITGA3). Loss of ITGA3 abolishes ??3??1 integrin expression and downstream signaling, impairing adhesion to laminin, collagen, and fibronectin, and blocking activation of FAK, Src, and the PI3K-Akt pathway. This knockout model is ideal for investigating integrin-mediated adhesion, migration, and survival in liver endothelial biology, cancer metastasis research, and anti-integrin drug screening. Researchers can utilize adhesion assays, phospho-FAK/Akt analysis, and migration/invasion assays to dissect ??3??1-dependent mechanisms.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    SK-HEP-1

    Sex of Donor

    Male

    Age

    52 years

    Gene Name

    ITGA3

    Gene Identifier

    NCBI Gene ID 3675

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ITGA3 Knockout SK-HEP-1 Polyclonal Cells comprise a CRISPR/Cas9-edited polyclonal cell population derived from the SK-HEP-1 human hepatic sinusoidal endothelial cell line, in which the integrin subunit alpha-3 gene (ITGA3) has been disrupted. This knockout model provides a loss-of-function system for investigating the cellular roles of the ??3??1 integrin heterodimer without clonal selection, preserving the inherent heterogeneity of the parental line. The polyclonal format enables functional genomics, drug target validation, and signaling studies in a population context, avoiding potential artifacts from single-cell cloning.

The SK-HEP-1 host cell line was established from the ascitic fluid of a patient with liver adenocarcinoma and exhibits phenotypic characteristics of hepatic sinusoidal endothelial cells. These cells line the hepatic sinusoids and participate in critical physiological processes including endocytosis, immune surveillance, and maintenance of liver homeostasis. Their endothelial origin makes them particularly relevant for modeling cell-matrix interactions, transendothelial migration, and the hepatic microenvironment in both normal and disease states.

ITGA3 encodes the integrin ??3 subunit, which pairs exclusively with integrin ??1 (ITGB1) to form the laminin-binding receptor ??3??1. This heterodimer mediates adhesion to extracellular matrix proteins such as laminin isoforms, collagen IV, and fibronectin, and serves as a critical nexus for biomechanical and biochemical signaling. Upon ligand engagement, ??3??1 activates focal adhesion kinase (FAK/PTK2) and Src family kinases, leading to downstream activation of the PI3K-Akt-mTOR axis and small GTPases Rac1 and RhoA, thereby promoting cell migration, proliferation, and survival. Additionally, ??3??1 interacts with tetraspanins (CD9, CD81), uPAR, and EGFR, modulating signaling crosstalk. Upstream regulators include TGF-?? and EGF, which can modulate ITGA3 expression, while laminin and collagen matrices provide the primary adhesive cues.

Disruption of ITGA3 in SK-HEP-1 cells eliminates functional ??3??1 integrin, thereby impairing adhesion to laminin-rich substrates and abrogating FAK/Src and PI3K/Akt-mediated signaling cascades. In the context of hepatic sinusoidal endothelium, this loss-of-function model is instrumental for dissecting the contribution of ??3??1 to endothelial barrier function, transendothelial migration of cancer cells, and fibrotic responses. The model is particularly relevant for studying liver cancer metastasis, where integrin-mediated adhesion and signaling are often dysregulated, and for anti-integrin therapeutic screening.

These polyclonal knockout cells are well-suited for a range of experimental applications, including quantitative adhesion assays on laminin or collagen matrices, Boyden chamber migration and invasion assays, and flow cytometric analysis of surface integrin expression. Researchers can employ Western blotting and phospho-specific antibodies to assess FAK (Tyr397) and Akt (Ser473) phosphorylation status, co-immunoprecipitation to examine integrin complex integrity, and immunofluorescence to visualize focal adhesion dynamics. The model also supports RT-qPCR for ITGA3 transcript quantification, cell viability assays under stress conditions, and high-content screening for compounds targeting integrin signaling pathways. For additional information, technical support, or to place an order, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)